Breaking News
Get 50% Off 0
📌 New AI-picked stocks coming soon. 3 picks from last month are already up +30%...
Get early access
Close

Oramed Pharmaceuticals Inc (ORMP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Oramed's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.175 -0.035    -1.58%
20:50:31 - Real-time Cboe. Currency in USD
Type:  Equity
Market:  United States
  • Volume: 125,132
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 2.150 - 2.250
Oramed 2.175 -0.035 -1.58%

Oramed Pharmaceuticals Inc Company Profile

 
Get an in-depth profile of Oramed Pharmaceuticals Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

4

Equity Type

ORD

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.

Contact Information

Address 1185 Avenue of the Americas Third Floor
New York, 10036
United States
Phone 844 967 2633
Fax -

Top Executives

Name Age Since Title
Yehuda Reznick 76 2024 Director
Leonard Sank 60 2007 Independent Director
Roy Eldor - 2016 Member of the Scientific Advisory Board
Avram Hershko 88 2008 Member of Scientific Advisory Board
Harold Jacob 71 2008 Member of Scientific Advisory Board
Eleuterio Ferrannini - 2007 Member of Scientific Advisory Board
Nadav Kidron 51 2006 President, CEO & Executive Chairman
Julio Rosenstock - 2020 Member of Scientific Advisory Board
Arie Mayer 69 2019 Independent Director
G. Alexander Fleming - 2019 Member of Scientific Advisory Board
Anne L. Peters - 2022 Member of Scientific Advisory Board
Benjamin Shapiro 40 2023 Independent Director
Daniel Aghion 43 2024 Independent Director
Jay S. Skyler 78 2020 Member of Scientific Advisory Board
Miriam Kidron 85 2006 Chief Scientific Officer & Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ORMP Comments

Write your thoughts about Oramed Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email